| Product Code: ETC8848123 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Parkinsons disease market in the Philippines is expanding as awareness and diagnosis rates increase. With an aging population and greater neurological care services, more patients are accessing treatment. The market includes drugs, therapy devices, and care services, though rural accessibility and affordability remain challenges.
The Parkinson`s disease market in the Philippines is experiencing growth as the prevalence of Parkinson`s disease, a progressive neurodegenerative disorder, continues to rise. The aging population, along with increased awareness and diagnosis of the disease, is contributing to the market`s expansion. Treatment options for Parkinsons disease, including medications, therapies, and surgical interventions, are in demand as patients seek to manage symptoms and improve their quality of life. The market for Parkinson`s disease treatments is expected to grow with ongoing research into more effective therapies and potential cures.
Challenges in the Parkinsons disease market include underdiagnosis, late-stage detection, and the scarcity of movement disorder specialists. Treatment costs are high, and access to neurologists and rehabilitation services is limited in non-urban areas. Additionally, support systems for caregivers and patients are underdeveloped, impacting quality of care.
The Philippines Parkinsons Disease market presents significant investment opportunities, fueled by the aging population and the increasing awareness of this neurodegenerative condition. As the number of individuals diagnosed with Parkinsons disease rises, the demand for early diagnosis and effective treatments also increases. This opens avenues for investments in research and development of new drugs, therapies, and medical devices for managing Parkinsons symptoms. Additionally, innovations in telemedicine and home care solutions for Parkinsons patients are likely to drive market growth, making this an attractive area for healthcare-focused investors.
The government of the Philippines has made efforts to support individuals with Parkinson`s Disease through healthcare policies that focus on improving access to diagnosis and treatment. The Philippine government promotes awareness campaigns to educate the public about Parkinsons Disease and the importance of early diagnosis. Policies also encourage the development and availability of specialized healthcare services, such as physiotherapy and support groups, while providing funding for research on Parkinsons Disease treatments and therapies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Parkinsons Disease Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Parkinsons Disease Market - Industry Life Cycle |
3.4 Philippines Parkinsons Disease Market - Porter's Five Forces |
3.5 Philippines Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Philippines Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Philippines Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Philippines Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Philippines Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of Parkinson's disease in the Philippines |
4.2.2 Growing elderly population in the country |
4.2.3 Advancements in medical research and technology for Parkinson's disease treatment |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease medications and treatment |
4.3.2 Limited access to specialized healthcare services in remote areas of the Philippines |
4.3.3 Lack of public healthcare infrastructure and support for Parkinson's disease management |
5 Philippines Parkinsons Disease Market Trends |
6 Philippines Parkinsons Disease Market, By Types |
6.1 Philippines Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Philippines Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Philippines Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Philippines Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Philippines Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Philippines Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Philippines Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Philippines Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Philippines Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Philippines Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Philippines Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Philippines Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Philippines Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Philippines Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Philippines Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Philippines Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Philippines Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Philippines Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Philippines Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Philippines Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Philippines Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Philippines Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Philippines Parkinsons Disease Market Export to Major Countries |
7.2 Philippines Parkinsons Disease Market Imports from Major Countries |
8 Philippines Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis for Parkinson's disease patients in the Philippines |
8.2 Number of neurologists specializing in movement disorders in the country |
8.3 Percentage of Parkinson's disease patients receiving regular follow-up care and therapy |
9 Philippines Parkinsons Disease Market - Opportunity Assessment |
9.1 Philippines Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Philippines Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Philippines Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Philippines Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Philippines Parkinsons Disease Market - Competitive Landscape |
10.1 Philippines Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Philippines Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |